Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Froehner

Showing results (51-60 of 191) with videos related to

Pageof 20
Sort By:
The Journal of Urology|October 10, 2019
Re: External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate CancerMichael Froehner, Rainer Koch, Christian Thomas
European Urology|October 6, 2012
Re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012;62:662-70Michael Froehner, Rainer Koch, Manfred P Wirth
Annals of Internal Medicine|September 13, 2013
Effect of age, tumor risk, and comorbidity in a U.S. population-based cohort of men with prostate cancerMichael Froehner, Rainer Koch, Manfred P Wirth
Urology|February 5, 2013
Prostate-specific antigen-negative prostate cancer recurrence?Michael Froehner, Nasreddin Abolmaali, Manfred P Wirth
Asian Journal of Andrology|June 4, 2013
Comorbidity and survival of patients selected for radical prostatectomy at an age of 75 years or olderMichael Froehner, Rainer Koch, Manfred P Wirth
European Urology|March 8, 2014
Re: Atiqullah Aziz, Matthias May, Maximilian Burger, et al. PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 2014;66:156-163Vladimir Novotny, Manfred P Wirth, Michael Froehner
European Urology|November 5, 2013
Re: Karim A. Touijer, Clarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino, James A. Eastham. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur Urol 2014;65:20-5Michael Froehner, Rainer Koch, Manfred P Wirth
European Urology|August 31, 2015
Re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038Michael Froehner, Rainer Koch, Manfred P Wirth
Journal of General Internal Medicine|July 12, 2012
Comorbidities, treatment and survivalMichael Froehner, Rainer Koch, Manfred P Wirth
European Urology|December 20, 2015
Re: Grace L. Lu-Yao, Peter C. Albertsen, Dirk F. Moore, Yong Lin, Robert S. DiPaola, Siu-Long Yao. Fifteen-year Outcomes Following Conservative Management Among Men aged 65 Years or Older with Localized Prostate Cancer. Eur Urol 2015;68:805-11Michael Froehner, Rainer Koch, Manfred P Wirth
Pageof 20

Showing results (51-60 of 191) with videos related to

Sort By:
Pageof 20
The Journal of Urology|October 10, 2019
Re: External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate CancerMichael Froehner, Rainer Koch, Christian Thomas
European Urology|October 6, 2012
Re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012;62:662-70Michael Froehner, Rainer Koch, Manfred P Wirth
Annals of Internal Medicine|September 13, 2013
Effect of age, tumor risk, and comorbidity in a U.S. population-based cohort of men with prostate cancerMichael Froehner, Rainer Koch, Manfred P Wirth
Urology|February 5, 2013
Prostate-specific antigen-negative prostate cancer recurrence?Michael Froehner, Nasreddin Abolmaali, Manfred P Wirth
Asian Journal of Andrology|June 4, 2013
Comorbidity and survival of patients selected for radical prostatectomy at an age of 75 years or olderMichael Froehner, Rainer Koch, Manfred P Wirth
European Urology|March 8, 2014
Re: Atiqullah Aziz, Matthias May, Maximilian Burger, et al. PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 2014;66:156-163Vladimir Novotny, Manfred P Wirth, Michael Froehner
European Urology|November 5, 2013
Re: Karim A. Touijer, Clarisse R. Mazzola, Daniel D. Sjoberg, Peter T. Scardino, James A. Eastham. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur Urol 2014;65:20-5Michael Froehner, Rainer Koch, Manfred P Wirth
European Urology|August 31, 2015
Re: Malte Rieken, Shahrokh F. Shariat, Luis A. Kluth, et al. Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.038Michael Froehner, Rainer Koch, Manfred P Wirth
Journal of General Internal Medicine|July 12, 2012
Comorbidities, treatment and survivalMichael Froehner, Rainer Koch, Manfred P Wirth
European Urology|December 20, 2015
Re: Grace L. Lu-Yao, Peter C. Albertsen, Dirk F. Moore, Yong Lin, Robert S. DiPaola, Siu-Long Yao. Fifteen-year Outcomes Following Conservative Management Among Men aged 65 Years or Older with Localized Prostate Cancer. Eur Urol 2015;68:805-11Michael Froehner, Rainer Koch, Manfred P Wirth
Pageof 20